The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Immunotherapy to prevent progression on active surveillance study (IPASS): A phase II, randomized, double-blind, controlled trial of PROSTVAC in prostate cancer patients who are candidates for active surveillance.
 
J Kellogg Parsons
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson; Pfizer
Honoraria - Dendreon; Janssen Medical Affairs
 
Peter A. Pinto
Patents, Royalties, Other Intellectual Property - Philips/In Vivo Inc pays royalties to NIH for a licensing agreement, NIH then pays royalties to Dr. Pinto. NIH and Philips have a CRADA. NIH has intellectual property in the field
 
Howard L. Parnes
Stock and Other Ownership Interests - Gilead Sciences; Health Care Select Sector; Illumina; Intellia Therapeutics; Intuitive Surgical; IQvia; Roche; Roper Technologies; Schlumberger
 
Christian P. Pavlovich
Consulting or Advisory Role - Dendreon
 
Edward M. Uchio
Research Funding - Ambry Genetics; Bayer; Bristol-Myers Squibb/Pfizer; CG Oncology; Clovis Oncology; Exact Sciences; GenomeDx; Genomic Health; Janssen Oncology; Merck; Merit Medical Systems; Myovant Sciences; Myovant Sciences; Myriad Genetics; Pfizer; Seagen; Veracyte
(OPTIONAL) Uncompensated Relationships - Bayer; Genomic Health; Janssen Oncology; Merck; Myriad Genetics; Pfizer
 
Mike Minh Nguyen
No Relationships to Disclose
 
Hyung Lae Kim
Research Funding - GenomeDx
Patents, Royalties, Other Intellectual Property - I am an inventor of a prognostic biomarker signature and immunotherapies.
 
James L. Gulley
Research Funding - Astellas Medivation (Inst); Bavarian Nordic (Inst); Bristol-Myers Squibb (Inst); EMD Serono (Inst); ImmunityBio (Inst); Incyte (Inst); Janssen Oncology (Inst); Merck (Inst); Pfizer (Inst)
 
Houssein Abdul Sater
No Relationships to Disclose
 
Christina Jamieson
No Relationships to Disclose
 
Chiu-Hsieh Hsu
No Relationships to Disclose
 
Malgorzata E. Wojtowicz
No Relationships to Disclose
 
Jeffrey Schlom
Research Funding - Bavarian Nordic (Inst); EMD Serono/Merck (Inst); ImmunityBio (Inst); Incyte (Inst); NextCure (Inst); PDS Biotechnology (Inst); Precigen (Inst)
Patents, Royalties, Other Intellectual Property - If applicable; If applicable (Inst)
 
Renee Nicole Donahue
No Relationships to Disclose
 
Sara Centuori
No Relationships to Disclose
 
Shania Bailey
No Relationships to Disclose
 
Julie E. Bauman
Research Funding - AstraZeneca (Inst); AVEO (Inst); Bristol-Myers Squibb (Inst); Celldex (Inst); CUE Biopharma (Inst); Lilly (Inst); Moderna Therapeutics (Inst); Novartis (Inst)
 
H H Chow
No Relationships to Disclose